Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib
Research Grant
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Pfizer, Inc.
Start Date
June 20, 2025
End Date
December 31, 2026
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Pfizer, Inc.
Start Date
June 20, 2025
End Date
December 31, 2026